Phase 1 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a known or suspected solid tumour (a type of cancer that forms a lump or mass).
- People who have at least one tumour or lesion that is 1.0 cm or larger in size, visible on standard scans such as CT, MRI, ultrasound, or PET/CT imaging.
Who may not be able to join:
- Women who are pregnant or breastfeeding at the time of screening, or women of childbearing age whose pregnancy test (taken within 2 weeks before screening) returns a positive result.
- People who, in the opinion of the trial doctor, would not be able to tolerate the imaging procedures involved in the study.
- People who have a current medical condition, illness, or disorder that a trial doctor considers could put them at risk or prevent them from safely completing the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lilie L Lin, M.D. Anderson Cancer Center
Phone: 713-563-2300
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Poly (ADP-ribose) polymerase inhibitor (PARP)-1 activity as assessed by fluorine F 18 fluorthanatrace positron emission tomography/computed tomography
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.